Stay updated on Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial
Sign up to get notified when there's something new on the Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial page.

Latest updates to the Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision label, v3.5.4, has been added. The previous revision label, v3.5.3, has been replaced.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe revision label in the page footer updated from v3.5.2 to v3.5.3, indicating a version bump for the site's software.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check77 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This is a minor update with no substantive changes to the page content.SummaryDifference0.0%

- Check106 days agoChange DetectedA new site revision (Revision: v3.4.2) was added and an older funding-status notice along with Revision: v3.4.1 were removed; these changes are administrative and do not affect the study details or content.SummaryDifference0.4%

Stay in the know with updates to Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial page.